Jefferies Financial Group Forecasts Strong Price Appreciation for Cardinal Health (NYSE:CAH) Stock

Cardinal Health (NYSE:CAH) had its price objective upped by analysts at Jefferies Financial Group from $220.00 to $270.00 in a report issued on Thursday,MarketScreener reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s price target suggests a potential upside of 29.34% from the stock’s previous close.

CAH has been the subject of a number of other reports. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Wells Fargo & Company upped their price target on shares of Cardinal Health from $221.00 to $237.00 and gave the company an “overweight” rating in a report on Thursday, January 15th. Evercore ISI lifted their price objective on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Friday, October 31st. Barclays began coverage on Cardinal Health in a research report on Monday, December 8th. They set an “overweight” rating and a $243.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a report on Tuesday, November 18th. Fourteen analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $219.67.

Cardinal Health Stock Up 0.1%

Shares of Cardinal Health stock opened at $208.75 on Thursday. Cardinal Health has a 52-week low of $120.72 and a 52-week high of $215.48. The company has a market capitalization of $49.60 billion, a P/E ratio of 31.49, a P/E/G ratio of 1.42 and a beta of 0.65. The company has a 50 day moving average of $205.71 and a 200 day moving average of $175.68.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company’s revenue was up 22.4% on a year-over-year basis. During the same period last year, the business earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, research analysts anticipate that Cardinal Health will post 7.95 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cardinal Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in shares of Cardinal Health by 0.8% during the third quarter. Vanguard Group Inc. now owns 30,823,483 shares of the company’s stock worth $4,838,054,000 after purchasing an additional 247,667 shares in the last quarter. Geode Capital Management LLC increased its stake in Cardinal Health by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after buying an additional 205,539 shares during the period. Wellington Management Group LLP lifted its holdings in Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares in the last quarter. Bank of America Corp DE boosted its position in Cardinal Health by 3.2% in the 3rd quarter. Bank of America Corp DE now owns 3,592,775 shares of the company’s stock valued at $563,922,000 after buying an additional 111,582 shares during the last quarter. Finally, Invesco Ltd. grew its stake in shares of Cardinal Health by 14.7% during the third quarter. Invesco Ltd. now owns 3,483,207 shares of the company’s stock valued at $546,724,000 after acquiring an additional 445,425 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.